Health Universe

Health Universe supplies its own clinical reasoning, oncology extraction and trial workflow agents through Navigator. Those functions depend on learned models, while the surrounding platform also provides record retrieval, application hosting, access controls and certification support that have value beyond any individual agent.

Clinicians can question Navigator's responses and inspect the supporting sources and confidence signals. Organizations can withdraw access to an unsafe application, and governance committees can review logs before deployment. Exact clinical escalation thresholds and the conditions requiring a person to approve each action are not specified.

The oncology extraction pipeline uses GPT 4o, multiple reasoning steps and structured schemas tailored to cancer type. It combines findings across documents into a patient profile. Model release identifiers, training data composition and the update schedule for the deployed agents are not specified.

GPT 4o identifies OpenAI's model family within the oncology pipeline, and Kno2 supplies the connection to the national record exchange. A complete inventory of model processors and infrastructure partners, with each recipient's retention and training terms, is not available for the full platform.

An internal March 2026 Navigator evaluation reports 73.3% average accuracy across nine MedHELM tasks. The table includes scoring methods and sample counts for eight tasks, with mixed results against the comparison model. This benchmark evaluates the reasoning layer alone and does not establish effects on patient outcomes.

The privacy terms permit training and commercialization using deidentified submitted data, while excluding records retrieved through TEFCA from those uses. Routine retention windows for identifiable records are unspecified. The safety framework describes constrained prompts, retrieval, monitoring and application removal, but no complete incident response protocol with clinical escalation thresholds.

Health Universe acts as a business associate for submitted PHI. Its standard business associate terms apply when a negotiated agreement is absent, including to authorized individual clinicians acting for a covered entity. The terms bind PHI handling subcontractors, require breach reporting and address return or destruction after termination.

The security program includes SOC 2 Type II coverage and an annual audit of security, availability and privacy controls. Health Universe also describes annual independent penetration tests, encryption, access controls and immutable activity logs. The audit report, current examination period and detailed scope are not available without further inquiry.

The platform supports record review, summarization and clinical workflows, with diagnosis and treatment responsibility assigned to clinicians. Its DSI platform version 1.0 has a named ONC health IT certification dated November 13, 2024. That certification covers decision support infrastructure and does not establish FDA device clearance for its agents.

The oncology evaluation compares extraction performance across six cancer types using expert curated reference data. F1 scores range from 90.7% for colorectal documents to 95.1% for breast documents. These results expose variation across clinical groups; they do not describe demographic performance or establish the same behavior across every hosted agent.

Navigator's benchmark supplies task definitions, scoring methods and sample counts alongside accuracy results, making those claims testable. Clinicians can trace an answer and challenge it through dialogue. The standard terms disclaim output warranties and leave clinical decisions with the customer; no general compensation promise attaches to an incorrect answer.

The record service retrieves information through TEFCA via Kno2 and supports SMART on FHIR access within clinical workflows. New York Cancer & Blood Specialists is a named deployment using the record and summary workflow. A documented production connection that both reads and writes a named major EHR is not specified.

The platform runs in a hosted environment with isolated organizational workspaces and permissions for people, records and agents. Organizations can bring their own applications into that environment. A committed hosting region, a complete processing geography and a customer controlled private deployment option are not specified.

Sales begin with a demo and pricing conversation. The DSI subscription can be charged by provider, site or EHR, with possible hosting, compute and integration fees. Current enterprise prices and the charging basis for Navigator's own agents are not specified, so the infrastructure units do not establish a complete agent budget.

The workflows target specialty physician networks, laboratories, senior care organizations, navigation teams and academic researchers. Oncology has named production use at New York Cancer & Blood Specialists and an extraction evaluation spanning six cancer types. Comparable validation across all the other settings and agent workflows is not specified.